TY - JOUR
T1 - Levels of cocaine- and amphetamine-regulated transcript in vagal afferents in the mouse are unaltered in response to metabolic challenges
AU - Yuan, Xuefeng
AU - Huang, Ying
AU - Shah, Sarita
AU - Wu, Hua
AU - Gautron, Laurent
N1 - Funding Information:
This work was supported by the American Neurogastroenterology and Motility Society Research Grant (2013-2014). The research reported in this publication was also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award #UL1TR001105.
Publisher Copyright:
© 2016 Yuan et al.
PY - 2016
Y1 - 2016
N2 - Cocaine- and amphetamineregulated transcript (CART) is one of the most abundant neuropeptides in vagal afferents, including those involved in regulating feeding. Recent observations indicate that metabolic challenges dramatically alter the neuropeptidergic profile of CARTproducing vagal afferents. Here, using confocal microscopy, we reassessed the distribution and regulation of CART(55–102) immunoreactivity in vagal afferents of the male mouse in response to metabolic challenges, including fasting and high-fatdiet feeding. Importantly, the perikarya and axons of vagal C-fibers were labeled using mice expressing channelrodhopsin- 2 (ChR2-YFP) in Nav1.8-Cre–expressing neurons. In these mice, approximately 82% of the nodose ganglion neurons were labeled with ChR2-YFP. Furthermore, ChR2-YFP–labeled axons could easily be identified in the dorsovagal complex. CART(55–102) immunoreactivity was observed in 55% of the ChR2-YFP–labeled neurons in the nodose ganglion and 22% of the ChR2-YFP–labeled varicosities within the area postrema of fed, fasted, and obese mice. The distribution of positive profiles was also identical across the full range of CART staining in fed, fasted, and obese mice. In contrast to previous studies, fasting did not induce melaninconcentrating hormone (MCH) immunoreactivity in vagal afferents. Moreover, prepro-MCH mRNA was undetectable in the nodose ganglion of fasted mice. In summary, this study showed that the perikarya and central terminals of vagal afferents are invariably enriched in CART and devoid of MCH.
AB - Cocaine- and amphetamineregulated transcript (CART) is one of the most abundant neuropeptides in vagal afferents, including those involved in regulating feeding. Recent observations indicate that metabolic challenges dramatically alter the neuropeptidergic profile of CARTproducing vagal afferents. Here, using confocal microscopy, we reassessed the distribution and regulation of CART(55–102) immunoreactivity in vagal afferents of the male mouse in response to metabolic challenges, including fasting and high-fatdiet feeding. Importantly, the perikarya and axons of vagal C-fibers were labeled using mice expressing channelrodhopsin- 2 (ChR2-YFP) in Nav1.8-Cre–expressing neurons. In these mice, approximately 82% of the nodose ganglion neurons were labeled with ChR2-YFP. Furthermore, ChR2-YFP–labeled axons could easily be identified in the dorsovagal complex. CART(55–102) immunoreactivity was observed in 55% of the ChR2-YFP–labeled neurons in the nodose ganglion and 22% of the ChR2-YFP–labeled varicosities within the area postrema of fed, fasted, and obese mice. The distribution of positive profiles was also identical across the full range of CART staining in fed, fasted, and obese mice. In contrast to previous studies, fasting did not induce melaninconcentrating hormone (MCH) immunoreactivity in vagal afferents. Moreover, prepro-MCH mRNA was undetectable in the nodose ganglion of fasted mice. In summary, this study showed that the perikarya and central terminals of vagal afferents are invariably enriched in CART and devoid of MCH.
KW - Immunohistochemistry
KW - Metabolism
KW - Neuropeptide
KW - Vagus nerve
UR - http://www.scopus.com/inward/record.url?scp=85018327392&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85018327392&partnerID=8YFLogxK
U2 - 10.1523/ENEURO.0174-16.2016
DO - 10.1523/ENEURO.0174-16.2016
M3 - Article
C2 - 27822503
AN - SCOPUS:85018327392
SN - 2373-2822
VL - 3
JO - eNeuro
JF - eNeuro
IS - 5
M1 - e0174-16.2016
ER -